Junhemeng Biopharmaceutical (jhm-biopharma.com): no confident changes recorded yet; website history since November 2026. Homepage last checked 6 November 2026.
First recorded website
Observed 6 November 2026
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
Recorded changes
Newest observations first. Each interval bounds when the website changed; it is not an exact event date.
No changes recorded yet. Missing observations do not mean the company has not changed.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messaging君合盟生物制药（杭州）股份有限公司
Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.
Synthorxsynthorx.comDirect competitorBoth use synthetic biology to engineer recombinant protein therapeutics for multiple disease areas.
Juvena (Juvena Therapeutics)juvenatherapeutics.comPartial overlapBoth develop protein therapeutics using advanced discovery and engineering platforms for tissue repair and disease.
Amolyt Pharmaamolytpharma.comPartial overlapBoth develop peptide or protein drugs targeting endocrine diseases.
Cite this record
StartupHistory, “Junhemeng Biopharmaceutical” company record, https://startuphistory.org/c/jhm-biopharma.com